Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes.
Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis.
Company Details
- Employees
- 20
- Founded
- -
- Address
- Parc Technologique De Lyon, 655 Allée Des Parcs,bâtiment D,france
- Phone
- +33(0)4 82 538 962
- Industry
- Biotechnology
- Website
- a-biodesign.com
- Keywords
- Oncology.
- HQ
- Saint-Priest, Rhône-Alpes
Advanced Biodesign Questions
Advanced Biodesign's helpline number is +33(0)4 82 538 962
Advanced Biodesign's website is a-biodesign.com
Advanced Biodesign's LinkedIn profile is https://fr.linkedin.com/company/advanced-biodesign
Advanced Biodesign has
20 employees.
View email and phone details for 20
employees at Advanced Biodesign.
Advanced Biodesign's industry is
Biotechnology
Advanced Biodesign's top competitors are
Acs Biotech,
Maat Pharma,
Biotuesdays Métropole De Lyon,
Axoltis Pharma,
Brenus Pharma,
Alzprotect Sas,
Stromacare,
Adocia,
Phaxiam Therapeutics,
Lys Therapeutics.
Advanced Biodesign's categories are Biotechnology
Advanced Biodesign's founding year is 2010
